# French Evaluation Group Avastin Versus Lucentis

> **NCT01170767** · PHASE3 · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 501 (actual)

## Conditions studied

- Age Related Macular Degeneration

## Interventions

- **DRUG:** Avastin
- **DRUG:** Lucentis

## Key facts

- **NCT ID:** NCT01170767
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 501 (ACTUAL)
- **Last updated:** 2019-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01170767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01170767, "French Evaluation Group Avastin Versus Lucentis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01170767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*